Q&A: What the Most-Favored-Nation Drug Pricing Executive Order Means for Community Pharmacy
Ronna Hauser, PharmD, Senior Vice President of Policy & Pharmacy Affairs at NCPA, provides insights into President Trump’s most recent executive order regarding manufacturer drug prices.
Why Digital Innovation Will Transform the Future of Smart Pharmacy | NCPDP 2025
NBC News Medical Analyst Vin Gupta, MD, joins Drug Topics at NCPDP 2025 to discuss the technological evolution of the pharmacy profession.
Freestyle Libre CGM Linked With Reduced Hospitalization Risk For Heart Complications in Patients With Diabetes
Abbott’s continuous glucose monitoring system is the first to show a reduction in cardiovascular complication severity.
Pharmacy Law Lowdown: PBM Audit Trends, Enforcement Actions
Dae Lee, PharmD, Esq, CPBS and Lucas Morgan, Esq, discuss PBM and board of pharmacy enforcement actions, trends in PBM audits, and more.
Adult-Onset Type 1 Diabetes Increases Risk of Cardiovascular Disease
Investigators also find that patients diagnosed with type 1 diabetes later in life do not have a better prognosis compared to those diagnosed earlier.
CGMs Can Reduce Nocturnal, Daytime Hypoglycemia for Patients With Type 1 Diabetes
Investigators also found that nocturnal hypoglycemia is a strong predictor of daytime hypoglycemia.
